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Initial axonal elongation is essential for neuronal polarization and requires polarized
activation of IGF-1 receptors (IGF-1r) and the phosphatidylinositol 3 kinase (PI3k) pathway.
Wingless-type family growth factors (Wnts) have also been implied in the regulation of
axonal development. It is not known, however, if Wnts have any participation in the
regulation of initial axonal outgrowth and the establishment of neuronal polarity. We used
cultured hippocampal neurons and growth cone particles (GCPs) isolated from fetal rat
brain to show that stimulation with the wingless family factor 3A (Wnt3a) was sufficient
to promote neuronal polarization in the absence of IGF-1 or high insulin. We also show
that Wnt3a triggered a strong activation of IGF-1r, PI3k, and Akt in developmental Stage
2 neurons and that the presence of activatable IGF-1r and PI3k activation were necessary
for Wnt3a polarizing effects. Surface plasmon resonance (SPR) experiments show that
Wnt3a did not bind specifically to the IGF-1r. Using crosslinking and immuno-precipitation
experiments, we show that stimulation with Wnt3a triggered the formation of a complex
including IGF-1r-Wnt3a-Frizzled-7. We conclude that Wnt3a triggers polarization of neurons
via cross-activation of the IGF-1r/PI3k pathway upon binding to Fz7.
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INTRODUCTION
The establishment of neuronal polarity requires the action of two
interrelated processes: axon specification and elongation. The ini-
tial signals and pathways that determine polarity are beginning to
be understood. A particularly early event that occurs in neurons
that have not yet exhibited a discernible axon (stage 2 of differ-
entiation) is the segregation of activatable, membrane inserted
IGF-1 receptors (IGF-1r) in a single neurite (Sosa et al., 2006).
Subsequently, phosphatidylinositol-3 kinase (PI3k) and its prod-
uct, phosphatidylinositol 3,4,5-trisphosphate (PIP3), accumulate
in the distal region and growth cone of the neurite with the
IGF-1r. These events are critical for the outgrowth of the future
axon, together with activation of PI3k by IGF-1r (Shi et al., 2003;
Sosa et al., 2006). Additionally, it has been shown that IGF-1
produces a robust and long lasting activation of the PI3k-Akt
pathway through activation of the IGF-1r in hippocampal neu-
rons (Zheng and Quirion, 2004). Activation of IGF-1r by their
cognate ligand (IGF-1) and by insulin is also able to transactivate
other receptor systems, such as epidermal growth factor receptors
(EGFRs) (Roudabush et al., 2000).
Growth factors belonging to the Wnt family have been impli-
cated in different aspects of axonal development (Rosso and
Salinas, 2007). There is increasing published evidence indicating
that Wnts are key mediators of axonal outgrowth and guidance
(Lyuksyutova et al., 2003; Arevalo and Chao, 2005) and regu-
late axonal remodeling through inhibition of GSK3β (Krylova
et al., 2000; Ciani et al., 2004). Interestingly one study showed
that Wnt5a could accelerate initial axonal outgrowth by acti-
vating aPKC and stimulating the interaction between Dv1 and
the polarity complex PAR3/PAR6/aPKC (Zhang et al., 2007).
However, the above mentioned experiments were made in the
presence of high insulin concentration, enough to fully acti-
vate the IGF-1r and trigger hippocampal neuron polarization in
the absence of any other growth factor (Dotti et al., 1988; Sosa
et al., 2006). Another member of the Wnt family, Wnt3a, has
been shown to be essential for hippocampal development (Lee
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et al., 2000) and regulates neurite outgrowth in neuroblastoma
cells (Greer and Rubin, 2011). The experiments in the present
paper were designed to investigate the involvement of Wnt family
members (specifically Wnt3a) in the regulation of initial axonal
outgrowth and the establishment of neuronal polarity. Moreover,
we studied a possible relationship between Wnt3a and the IGF-1r
pathway.
Using cultured hippocampal pyramidal neurons and growth
cone particles (GCPs) prepared from fetal rat brain (GCPs),
our results show that Wnt3a strongly stimulated the IGF-1r
and the PI3k pathway through the formation of an IGF-1r
(active)-Wnt3a-Frizzled-7 (Fz7) complex and, therefore, stimu-
lated initial axonal outgrowth and the establishment of neuronal
polarity.
MATERIALS AND METHODS
PRIMARY ANTIBODIES
The following primary antibodies were used: affinity-purified
rabbit polyclonal antibody against βgc (Quiroga et al., 1995),
which was diluted 1:200 for immunofluorescence and 1:500
for western blotting; mouse monoclonal antibody against
IGF-1r clone αIR3 (Calbiochem), which was diluted 1μg/ml
for immunoprecipitation; rabbit monoclonal antibody against
Frizzled-7 receptor (Sigma-Aldrich), which was diluted 1:500 for
western blotting; rabbit polyclonal antibody to the phosphory-
lated (tyr 458) binding motif of p85 PI3k (Cell Signaling), which
was diluted 1:200 for immunofluorescence and 1:1000 for west-
ern blotting; anti PI3k p85 rabbit monoclonal antiserum (Cell
Signaling), which was diluted 1:1000 for western blotting; mouse
monoclonal antibody against TrkB (Santa Cruz Biotechnology),
which was diluted 1:100 for western blotting; rabbit polyclonal
antibody to phosphorylated IGF-1r (Tyr 980) (Cell Signaling),
which was diluted 1:100 for immunofluorescence and 1:1000
for western blotting; goat monoclonal antibody against phos-
phorylated TrkB receptor (Santa Cruz Biotechnology), which
was diluted 1:200 for western blotting; rabbit polyclonal anti-
body against the Ror2 receptor (Cell Signaling), which was
diluted 1:500 for western blotting; rabbit monoclonal anti-
body against Wnt3a (Cell Signaling), which was diluted 1:50
for immunoprecipitation and 1:500 for western blotting; mouse
monoclonal antibody against GAP-43 (Sigma-Aldrich), which
was diluted 1:500 for western blotting; mouse monoclonal anti-
body to the axonal marker Tau-1 (Calbiochem), which was
diluted 1:800 for immunofluorescence; rabbit monoclonal anti-
body to β-III-tubulin (Sigma-Aldrich), which was diluted 1:6000
for immunofluorescence and 1:4000 for western blotting; mouse
monoclonal antibody (clone 9F10) to c-myc (Roche Diagnostics,
Germany) which was diluted 1:400 for immunofluorescence; rat
monoclonal antibody to neural cell adhesion molecule L1 clone
324 (Millipore) 1μg/ml and rabbit polyclonal antibody to phos-
phorylated Akt (Santa Cruz Biotechnology), which was diluted
1:500 for western blotting.
ANIMALS
All animal procedures were performed following approved proto-
cols by the Board of AnimalWelfare, School of Chemical Sciences,
National University of Córdoba, Argentina.
CELL CULTURE
Dissociated hippocampal pyramidal cells were prepared from
embryonic rat brain and cultured as previously described
(Mascotti et al., 1997). To allow for neuronal survival, the
medium contained a low level of insulin (5 nM), which was suf-
ficient to stimulate insulin receptors but not fully activate IGF-1r
[It has been reported that the affinity of IGF-1r for insulin is 100–
500-fold lower than for its cognate ligand IGF-1 (Ballard et al.,
1988); previous published experiments from our laboratory indi-
cated that insulin significantly induced neuronal polarization at
concentrations of 100 nM or higher (Grasso et al., 2013)]. Where
indicated, 1.35 nMWnt3a (Purro et al., 2008) or 20 nM IGF-1 [we
have previously shown that IGF-1r was fully activated by IGF-1
at concentrations of 10 nM or higher (Quiroga et al., 1995)] was
added to the culture medium. Neurons were considered to be at
stage 3 when the length of the axon (positive to immunostaining
with Tau-1) exceeded that of the average length of minor neurites
by at least 20μm (Craig and Banker, 1994).
CELL TRANSFECTION
cDNAs encoding shRNAs were inserted in a dicistronic vec-
tor pSuper.neo + GFP (pSuper RNAi System-OligoEngine)
under the control of the H1 RNAIII polymerase pro-
moter, and the transfection marker GFP was under the
control of the PGK promoter. The target DNA sequence
was GCCCATGTGTGAGAAGACC (Bohula et al., 2003;
Sosa et al., 2006). A scrambled DNA target sequence
(GAACGGTCGCAGTGTACCA) was created using the siRNA
WizardTM, InvivoGen. The resulting plasmids were referred to
as IGF-1r shRNA and scrambled sequence RNA (ssRNA). The
Fz7 CRD was a generous gift from Dr. P. Salinas. The myc tagged,
constitutively active p110 construct was a generous gift from Dr.
L. Williams. The plasmids were mixed with Lipofectamine 2000
and added to the neurons 2 h after plating.
BLOCKING IGF-1r WITH ANTIBODIES
Neurons were grown in the presence of the mouse monoclonal
antibody clone αIR3 (diluted to 1μg/ml), which blocks the acti-
vation of IGF-1r. Clone αIR3 binds to an epitope within the
α-subunit adjacent to the ligand binding site and blocks IGF-1
from binding to its receptor without affecting either insulin or
IGF-II receptors (Kull et al., 1983; Rohlik et al., 1987). Clone
αIR3 cross-reacts with the α-subunit of rat IGF-1r and has been
extensively used in IGF-1r blocking experiments (Linseman et al.,
2002; Sosa et al., 2006). Fresh antibody was added to the culture
medium every 8 h.
PI3k INHIBITION
Neurons were grown in the presence (20μM) or absence of
the specific pharmacologic inhibitor of PI3k enzyme LY294002
(Sigma-Aldrich).
IMMUNOFLUORESCENCE
Cells were fixed and processed as previously described (Dupraz
et al., 2009). Cells were observed using a Zeiss Pascal 5 confocal
microscope. Images were captured and digitized using LSM Image
software, all images were printed using Adobe Photoshop. The
images were analyzed using ImageJ and/or StatSoft software.
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FIGURE 1 | Wnt3a triggered hippocampal neuron polarization. (A)
Double immunofluorescence micrographs of hippocampal neurons after 20 h
in culture showing the distribution of the neuronal marker β-III tubulin (tub)
and the axonal marker Tau-1. Cells were cultured in control medium (5 nM
insulin, top) or in medium containing either 20 nM IGF-1 (middle) or 1.35 nM
Wnt3a (bottom). (B) Percentage (±sem) of neurons at different stages of
differentiation grown for 20 h in control medium or in the presence of either
20 nM IGF-1 or 1.35 nM Wnt3a (n = 3 independent experiments). At least 100
cells were scored for each condition. ∗p < 0.005 compared to control.
(C) Percentage (±sem) of neurons at different stages of differentiation grown
in control medium or in the presence of 1.35 nM Wnt3a or 1.35 nM Wnt3a
plus different concentrations of sFRP-1. Note the significant dose-dependent
inhibition of Wnt3a-mediated polarizing effects of sFRP-1 (n = 3 independent
experiments). At least 100 neurons were scored for each condition.
∗p < 0.005 compared to control. Scale bar 100μm. (D) Percentage (±sem) of
neurons at different stages of differentiation grown for 20 h in the presence
of 1.35 nM Wnt3a and for further 24 h in the presence (or not) of 33.6 nM
sFRP-1 (n = 3 independent experiments) At least 100 neurons were scored
for each condition. ∗p < 0.02 compared to Wnt3a. Neurons were considered
to be at Stage 3 when the length of one of the processes positive to Tau-1
exceeded that of the average minor neurite by at least 20μm. (E) Average
length (±sem) of axons from neurons treated as in panel (D). (n = 3
independent experiments) At least 100 neurons were scored for each
condition. ∗p < 0.02 compared to Wnt3a.
IMMUNOFLUORESCENCE OF ACTIVE IGF-1r AND ACTIVE PI3k
Cells were cultured as previously described. After 12 h in culture,
cells were stimulated for 5min with 20 nM IGF-1 or 1.35 nM
Wnt3a, fixed, and processed for immunofluorescence using an
antibody selective for the phosphorylated form of IGF-1r (Sosa
et al., 2006) or a specific antibody against the phosphorylated
form of the PI3k regulatory subunit p85 (Sosa et al., 2006).
ISOLATION OF GROWTH CONES
Axonal growth cones were isolated from developing brain as pre-
viously described (Pfenninger et al., 1983; Lohse et al., 1996).
Briefly, brains of fetal rats at 18 days of gestation were homoge-
nized. A low-speed supernatant (LSS) was prepared, loaded onto
a discontinuous sucrose density gradient with steps of 0.83M and
2.66M sucrose, and spun to equilibrium at 242,000 g. The frac-
tion at the load/0.83M interface (designated “A”) contained the
GCPs.
IMMUNOPRECIPITATION EXPERIMENTS
Intact GCPs were incubated for 30min in the presence or absence
of Wnt3a (1.35 nM). To stabilize the ligand-receptor complexes,
we used the membrane insoluble and cleavable crosslinker
DTSSP, Pierce Protein Research Product, (1mM) following the
manufacturer protocols. GCPs were spun down for 6min at
4000 g, and the pellet was lysed with 1X RIPA buffer containing
3mM vanadate and a protease inhibitor cocktail. For immuno-
precipitation, the supernatant was incubated with the indicated
antibodies for 2 h at 4◦C before adding protein A/G plus-coated
beads. In some experiments (Figure 7D), total protein from hip-
pocampal neurons in culture (in control conditions or stimulated
with Wnt3a) was used as starting material.
GEL ELECTROPHORESIS ANDWESTERN BLOT ANALYSIS
Proteins were separated by SDS-polyacrylamide gel electrophore-
sis, transferred to PVDF membranes and developed with ECL on
x-ray films as previously described (Dupraz et al., 2009), or were
analyzed using a Li-COR Odyssey Infrared Imaging System (LI-
COR Biosciences) according to the manufacturer’s instruction.
SURFACE PLASMON RESONANCE (SPR) ASSAY
The interaction of soluble recombinant human Insulin-like
Growth Factor-1 (IGF-1) with its receptor (IGF-1r-recombinant
human Met 1-Asn 932 extracellular moiety; R&D System,
Minneapolis, USA) was measured by SPR analysis using a Biacore
T100 instrument (Biacore Inc, Piscataway, NJ), that allows to
determine the interactions between two molecules in real time
(Karlsson et al., 1991). IGF-1r (ligand, 1.0μg/ml) was dia-
lyzed against 10mM sodium acetate pH 4.5 and coupled to the
carboxymethyl-dextran matrix of CM5 sensor chips (Biacore)
using the Amine Coupling Kit as described (Johnsson et al., 1991).
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FIGURE 2 | Wnt3a elicited the polarized activation of IGF-1r and PI3k in
hippocampal neurons. (A) Western blots of active (phosphorylated) IGF-1r
(left) and phosphorylated p85 (right) in control GCPs and GCPs stimulated
with either 20 nM IGF-1 or 1.35 nM Wnt3a. Growth cone particles were
incubated for 30min on ice with growth factors and incubated at 37◦C for
5min in the presence of 1mM ATP. Note the noticeable increment in both
the active form of IGF-1r (left) and phosphorylated p85 (right). IGF-1r (left) or
total p85 (right) were included as loading controls. (B) Relative optical
densities of active IGF-1r and phosphorylated p85 in the western blots
[similar to those shown in panel (A)]. Note the significant increment of both
active IGF-1r and phosphorylated p85 in the GCPs stimulated with IGF-1
(∗p < 0.01; ∧p < 0.05) or Wnt3a (∗∗p < 0.001; ∧p < 0.05) compared with
control. Values are the average + sem of three independent experiments.
(C) Western blots of active (phosphorylated) Akt in control GCPs or GCPs
stimulated with either 20 nM IGF-1 or 1.35 nM Wnt3a. Growth cone particles
were kept on ice for 30min with the growth factors and incubated at 37◦C for
5min in the presence of 1mM ATP, p85 was included as a loading control.
(D) Western blots of active (phosphorylated) TrkB receptors in control GCPs
or GCPs stimulated with 20 nM IGF-1, 1.35 nM Wnt3a, or 50 ng/ml BDNF.
Growth cone particles were kept on ice for 30min with the growth factors
and incubated at 37◦C for 5min in the presence of 1mM ATP. Total TrkB was
included for comparison. (E) Double immunofluorescence micrographs of
hippocampal neurons after 12 h in culture showing the distribution of the
neuronal marker β-III tubulin (tub) and active IGF-1r (p-IGF-1r). Cells were
cultured in control medium (control) and challenged for 5min with either
20 nM IGF-1 (middle) or 1.35 nM Wnt3a (bottom). Note that active IGF-1r was
polarized to one neurite in the cells challenged with either IGF-1 (middle
arrowhead) or Wnt3a (bottom arrowhead) in stage 2 neurons that had not
exhibited a discernible axon. (F) Double immunofluorescence micrographs of
hippocampal neurons after 12 h in culture showing the distribution of the
neuronal marker β-III tubulin (tub) and phosphorylated p85 (p-p85). Cells were
cultured in control medium (control) and challenged for 5min with 20 nM
IGF-1 (middle) or 1.35 nM Wnt3a (bottom). Note that phosphorylated p85 was
polarized to one neurite in the cells challenged with either IGF-1 (middle
arrowhead) or Wnt3a (bottom arrowhead) in stage 2 neurons that had not
exhibited a discernible axon. Scale bars: 20μm.
The activation and immobilization periods were set between
3 and 7min to couple the desired amount of proteins yield-
ing between 1200 and 2000 resonance units (RU). Recombinant
human IGF-1 (analyte) was dialyzed against phosphate-buffered
saline (PBS) containing 150mMNaCl and twofold dilutions were
made in the same buffer.
In order to characterize the direct interaction between IGF-1r
and mouse Wnt3a or Fz7 [Recombinant Human FZD7/frizzled-
7 Protein, made in HEK293 (aa 45–169-Speed Biosystems, MD,
USA) preincubated with Wnt3a] IGF-1r was immobilized on
a CM5 sensor chip surface, as described above. Recombinant
Wnt3a was reconstituted in PBS-0.55% of bovine serum albu-
min (BSA), and twofold dilutions were made in the same
buffer.
All binding experiments were performed at 25◦C. Dissociation
was carried out in PBS. Pulses of PBS were used to regenerate the
surface. SPR data were analyzed using Biacore T100-evaluation
2.0.1 software (Biacore). All the experiments were repeated at least
three times and the standard deviations were typically less than
10%. Dissociation constants (KD) and association and dissoci-
ation rates (kon and koff, respectively), were determined under
kinetic conditions after correction for non-specific binding, in
which the proteins were passed over blocked, no immobilized
surfaces, as previously described (Fernandez et al., 2007, 2011).
RESULTS
Wnt3a TRIGGERED POLARIZATION OF HIPPOCAMPAL NEURONS IN
CULTURE AS WELL AS POLARIZED ACTIVATION OF IGF-1r AND PI3k
IGF-1r (activated by IGF-1 and/or insulin) controls initial
axonal elongation in hippocampal neurons by activating the
PI3k/Akt/Cdc42 pathway (Sosa et al., 2006). To study the possi-
ble involvement of the Wnt growth factor family Wnt3a on this
process, we cultured pyramidal hippocampal neurons in “con-
trol” conditions (in the presence of 5 nM insulin), and in the
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FIGURE 3 | An IGF-1r blocking antibody or the PI3k inhibitor
LY294002 hindered the polarizing effects of Wnt3a. (A) Double
immunofluorescence micrographs of hippocampal neurons after 20 h in
culture showing the distribution of the neuronal marker β-III tubulin (tub)
and the axonal marker Tau-1, Cells were cultured in medium containing
1.35 nM Wnt3a plus an antibody to L1 (top), 1.35 nM Wnt3a plus the IGF-1r
blocking antibody αIR3 (middle), or 1.35 nM Wnt3a plus the PI3k inhibitor
LY294002 (bottom). (B) Percentage (±sem) of neurons at different stages
of differentiation grown for 20 h in medium containing 1.35 nM Wnt3a plus
the anti-L1 antibody, 1.35 nM Wnt3a plus the IGF-1r blocking antibody αIR3,
or 1.35 nM Wnt3a plus the PI3k inhibitor LY294002 (n = 3 independent
experiments). At least 100 cells were scored for each condition. ∗p < 0.001
compared with Wnt3a + L1; ∗∗p < 0.001 compared with Wnt3a
(Figure 1B, right). Scale bar: 100μm.
presence of either 20 nM IGF-1 or 1.35 nM Wnt3a. Figure 1A
shows that most neurons cultured in control conditions for 20 h
failed to form axons; only short, minor neurites were present
(Figure 1A, top). In contrast, most cells cultured in the pres-
ence of IGF-1 (Figure 1A, middle) orWnt3a (Figure 1A, bottom)
generated long, axon-like processes that were enriched in Tau-
1 protein. To analyze this observation quantitatively, we scored
the differentiation stages of neurons cultured for 20 h in control
conditions or in the presence of IGF-1 or Wnt3a. We found that
over 80% of the cells cultured in control conditions remained in
stages 1 or 2 of differentiation, and less than 20% had formed
a discernible axon (stage 3). In contrast, over 55% of the cells
cultured in either the presence of IGF-1 or Wnt3a showed an
identifiable Tau-1 containing axon (Figure 1B). To determine the
specificity of Wnt3a axogenic effects, we used the Wnt path-
way antagonist secreted frizzled-related protein 1 (sFRP-1), which
binds to Wnt proteins (Rattner et al., 1997). Our results showed
that sFRP-1 dose-dependently inhibited Wnt3a polarizing effects
(Figure 1C). To investigate the possible role of Wnt3a in axon
maintenance, we scored the differentiation stages in neurons cul-
tured for 20 h in the presence of 1.35 nM Wnt3a (at this time
over 50% of the neurons were in stage 3-see Figure 1B). Then,
33.6 nM sFRP1 was added to half of the cultures and the neu-
rons were grown for further 24 h. We found that over 60% of
the neurons cultured in the presence of Wnt3a for 44 h were
in stage 3 of differentiation, in contrast less that 30% of the
cells were in this stage when sFRP-1 was added to the cultures
(Figure 1D). We also measured axonal length in neurons cul-
tured as in Figure 1D. Our results indicated a significant reduc-
tion of axonal outgrowth in the neurons treated with sFRP-1
(Figure 1E).
Next, we investigated the possible relationship betweenWnt3a
axogenic effects and the activation of the IGF-1r/PI3k path-
way. We initially analyzed the activation of IGF-1r in GCPs
challenged with 20 nM IGF-1 or 1.35 nM Wnt3a using a spe-
cific antibody for the active (phosphorylated) form of the
IGF-1r. We found that Wnt3a significantly activated IGF-1r
to a higher degree than the cognate ligand IGF-1 (Figure 2A,
left). In addition, Wnt3a also significantly activated PI3k
(Figure 2A, right). Quantification of these results (by measur-
ing the optical density of the different bands in the west-
ern blots) is shown in Figure 2B. Our results also showed
a noticeable activation of Akt, a kinase downstream of PI3k
(Figure 1C). We also analyzed the possible Wnt3a-induced acti-
vation of another tyrosine-kinase receptor, TrkB (the BDNF
receptor), which is enriched at the growth cone of neurons
(Pfenninger et al., 2003). Our results show that Wnt3a did
not cause any noticeable activation of TrkB (Figure 2D). In
the present study, we found that challenging the neurons with
1.35 nM Wnt3a resulted in a distribution of active IGF-1r that
was essentially identical to that achieved upon challenge with
20 nM IGF-1 (Figure 2E-middle and bottom). We also found
that challenging with either 20 nM IGF-1 or 1.35 nM Wnt3a
resulted in a polarized distribution of phosphorylated p85, the
PI3k regulatory subunit, to one neurite of cells in stage 2
(Figure 2F).
TRIGGERING OF INITIAL AXONAL OUTGROWTH AND THE
ESTABLISHMENT OF NEURONAL POLARITY BY Wnt3a REQUIRED THE
PRESENCE OF ACTIVATABLE IGF-1r AND ACTIVATION OF PI3k
To further investigate the relation between Wnt3a and the
IGF-1r/PI3k pathway on the establishment of neuronal polar-
ity, we designed experiments to study the possible mechanism(s)
by which Wnt3a stimulates IGF-1r and PI3k. Our results indi-
cate that the addition of an IGF-1r blocking antibody prevented
polarization of Wnt3a-challenged neurons (Figure 3A, middle),
compared with cells cultured in the presence of a monoclonal
antibody to the neural adhesion molecule L1 added at the same
protein concentration (Figure 3A, top); therefore, most of these
neurons remained at stage 2 after 20 h in culture (Figure 3B).
Moreover, in loss of function experiments using a shRNA derived
from the IGF-1r sequence (which uniformly silenced the expres-
sion of βgc-containing IGF-1r, shown in Figures 4A,B) (Sosa
et al., 2006) we observed that the silenced cells challenged with
Wnt3a failed to form axons and generated only short, minor
processes (Figure 4A). To analyze this observation quantitatively,
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FIGURE 4 | Wnt3a polarizing effects required normal expression of
IGF-1r. (A) Triple immunofluorescence micrographs of hippocampal neurons
after 24 h in culture showing the distribution of the IGF-1r βgc subunit, a
scrambled sequence RNA (GFP, top) or IGF-1r targeted shRNA (GFP, bottom),
and the neuronal marker β-III tubulin (tub). Cells were cultured in medium
containing 1.35 nM Wnt3a. The ssRNA transfected cells (top) showed a
normal morphology. In contrast, the shRNA transfected cells (bottom) did not
develop an axon. (B) Western blots showing protein levels of βgc, the Wnt
receptor Fz7 (to control specificity, also serves as loading control) and cells
transfected with a scrambled RNA sequence (ssRNA), and cells transfected
with IGF-1r shRNA (shRNA). We observed a substantial decrease in βgc
expression in the shRNA treated cells. (C) Percentage (±sem) of neurons at
different specific stages of differentiation grown for 20 h in culture in control
medium or in the presence of 1.35 nM Wnt3a and transfected with a
scrambled sequence RNA (ssRNA) or IGF-1r targeted shRNA (shRNA) (n = 3
independent experiments). At least 100 transfected cells (GFP positive) were
scored for each condition. ∗p < 0.005 compared to ssRNA + Wnt3a. Scale
bar: 20μm. (D) Immunofluorescence of hippocampal neurons after 24 h of
DIV showing the distribution of myc (marker of transfection with cDNA
encoding for a constitutively active form of the PI3k catalytic subunit p110).
GFP is a marker of transfection efficiency with the shRNA directed to
IGF-1r.Calibration bar = 20μm. (E) Percentage (±sem) of neurons at different
specific stages of differentiation grown for 20 h in culture in the presence of
1.35 nM Wnt3a and transfected with IGF-1r shRNA (shRNA) or co-transfected
with shRNA and a constitutively active form of the PI3k catalytic subunit p110
(p110CA). n = 3 independent experiments. Thirty or more transfected or
co-transfected cells were scored in each experiment. ∗p < 0.02 compared to
shRNA.
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FIGURE 5 | Wnt3a interaction with IGF-1r. (A) Growth cone particles were
stimulated with Wnt3a and immunoprecipitated with a non-relevant primary
antibody (IP control) or the αIR3 antibody to pull down IGF-1r. Blots were
probed with an anti-Wnt3a antibody. Immunoprecipitation of αIR3 is shown
to confirm successful IP and as a loading control. (B–D) Growth cone
particles were incubated in control buffer or in the presence of 1.35 nM
Wnt3a, immunoprecipitated with anti-Wnt3a and probed with (B) βgc
antibody to reveal IGF-1r; (C) anti-Ror2; and (D) anti-TrkB (BDNF receptor
prominent at the growth cone of developing neurons) Immunoprecipitation of
Wnt3a is shown to confirm successful IP and as a loading control. IP,
immunoprecipitate; S, soluble fraction after immunoprecipitation. All blots are
representative of at least three independent experiments.
FIGURE 6 | Surface Plasmon Resonance Analysis. (A) SPR sensogram of
the interaction between hIGF-1 (1600–100 nM) and IGF-1r (1600RU
immobilized) after correction for non-specific binding. (B) The apparent KD for
the binding of hIGF-1 to immobilized IGF-1r was 1.3 × 10−7 M by kinetic
analysis. kon and koff from where KD was calculated are also shown. (C) SPR
sensogram of the interaction between soluble Wnt3a (3125–100 nM) and
IGF-1r (1600RU). (Inset) The linear dependence of the response in function of
the concentration of soluble Wnt3a injected over immobilized IGF-1r support
the idea of non-specific direct binding. (D) Soluble IGF-1r (7.75–500 nM)
showed no specific biding to immobilized Wnt3a.
we scored the differentiation stages of neurons transfected with
a scrambled sequence RNA (ssRNA) or with IGF-1r targeted
shRNA after 24 h in culture. Quantification showed that only
about 6% of shRNA-transfected neurons formed a discernible
axon when challenged with Wnt3a, whereas 45% of controls
containing ssRNA formed axons (Figure 4C). Since PI3k oper-
ates downstream of the IGF-1r and to eliminate possible arti-
facts due to toxic or deleterious effects of transfection with
the shRNA, we cotransfected cells with the IGF-1r shRNA and
with a cDNA encoding a myc-tagged constitutively active form
of PI3k, p110. The results showed that co-transfection com-
pletely rescued the phenotype (Figure 4D), with over 90% of
co-transfected cells exhibiting long, axon-like processes compared
to less than 10% of cells transfected with IGF-1r shRNA alone
(Figure 4E).
Most cells challenged with Wnt3a in the presence of the
PI3k inhibitor LY294002 also failed to form axons (Figure 3A,
bottom). As shown in Figure 3B, less that 10% of the neurons
were in stage 3 after 24 h in culture, which was in contrast to
Wnt3a-challenged neurons cultured in the absence of the PI3k
inhibitor.
Wnt3a ACTIVATED THE IGF-1r-PI3k PATHWAY THROUGH THE
FORMATION OF AN ACTIVE IGF-1r-Fz7-Wnt3a COMPLEX
To further study the association between Wnt3a and the IGF-
1r, we performed immunoprecipitation experiments using GCPs
challenged withWnt3a and crosslinked with 3,3′-dithiobis (sulfo-
succinimidylpropionate). The results revealed that an antibody to
IGF-1r (clone αIR3) co-immunoprecipitated Wnt3a (Figure 5A).
In addition, an antibody to Wnt3a co-immunoprecipitated
IGF-1r in GCPs challenged with Wnt3a prior to crosslink-
ing and immunoprecipitation (Figure 5B). Ror2 is a tyrosine
kinase Wnt3a co-receptor found in non-neuronal cells (Li et al.,
2008), and shown to be highly enriched at the leading edge
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FIGURE 7 | Activation with Wnt3a triggers the formation of a
IFG-1r/Wnt3a/Fz7 complex. (A) Fz7 is enriched in GCPs. Western blot
analysis of the distribution of the Wnt receptor Fz7 in different subcellular
fractions of fetal brain: homogenate (H), low-speed supernatant (LSS),
A-fraction (A), and growth cone particles (GCPs). Equal amounts of protein
were loaded in all lines. Note the enrichment of Fz7 in GCPs around
fourfold compared to (H). A blot showing the distribution of GAP-43, a
protein highly enriched in GCPs, was included for comparison. (B,C) Wnt3a
triggered the formation of a complex containing IGF-1r-Wnt3a-Fz7. Growth
cone particles were incubated in control buffer or in the presence of
1.35 nM Wnt3a and immunoprecipitated with (B) Anti Wnt3a and probed
with an antibody to the Wnt receptor Fz7 and (C) immunoprecipitated with
βgc antibody to pull down IGF-1r and probed with anti Fz7.
Immunoprecipitation of Wnt3a and βgc are shown to confirm successful IP
and as a loading control. IP, immunoprecipitate; S, soluble fraction after
immunoprecipitation. (D) Total protein from hippocampal neurons cultured
for 20 h in the presence of 1.35 nm Wnt3a, deprived of any growth factor
for 4 h, and stimulated (or not) with 1.35 nM Wnt3a for 5min
immunoprecipitated with anti βgc antibody to pull down the IGF-1r and
probed with anti Fz7. Immunoprecipitation of βgc is shown to confirm
successful IP and as a loading control. IP, immunoprecipitate; S, soluble
fraction after immunoprecipitation. All blots are representative of at least
three independent experiments.
of hippocampal pyramidal neurons in culture (Paganoni and
Ferreira, 2005). After crosslinking of GCPs challenged with
1.35 nM Wnt3a, we did not observe co-immunoprecipitation
of Ror2 with the Wnt3a antibody (Figure 5C). Another promi-
nent tyrosine kinase receptor of the growth cone in develop-
ing neurons is TrkB, the BDNF receptor, which also failed to
co-immunoprecipitate with the Wnt3a antibody (Figure 5D).
Taken together, these results indicate that only IGF-1r co-
immunoprecipitated with Wnt3a, whereas related tyrosine kinase
receptors, such as Ror2 and TrkB, did not. These experiments,
together with those indicating that the IGF-1r blocking antibody
prevents Wnt3a axogenic effects, suggested a possible direct inter-
action between Wnt3a and the IGF-1r. To assess this issue we
performed surface plasmon resonance (SPR) experiments. To val-
idate the method employed, the affinity between IGF-1 and its
cognate receptor, the IGF-1r, was determined. Twofold dilutions
of IGF-1 (1.6–0.1μM) were passed on immobilized IGF-1r for
60 s and response units (RU) were recorded. Dissociation was
carried out using PBS. The sensogram showed specific interac-
tion (Figure 6A) and the kinetic parameters were calculated with
the Biacore T100 Evaluation software fitting to a 1:1 binding
model (Figure 6B). These results are in line with those found
in the literature (Surinya et al., 2008). In contrast, when dif-
ferent concentrations of soluble Wnt3a were passed on IGF-1r,
no specific binding could be detected (Figure 6C). This could
also be appreciated by the linear response in the graphic of
the RU in function of the concentration (Figure 6C, inset). To
preclude any possibility of inactivation of the Wnt3a binding
site by immobilization of IGF-1r, an interaction analysis in the
reverse orientation was made. Thus, Wnt3a was immobilized
(3500 RU) and different concentration of IGF-1r were assayed
as analyte. Figure 6D shows no binding of these molecules cor-
roborating the previous result that there is no direct interaction
between these proteins in an isolated system. These results raised
the possibility that binding of Wnt3a to IGF-1r and its conse-
quent activation could be achieved through the formation of a
complex via binding of Wnt3a to a cognate receptor protein.
We found that the Wnt family receptor Fz7 is highly enriched
at the growth cone of differentiating neurons (Figure 7A).
As expected, the Wnt3a antibody co-immunoprecipitated Fz7
(Figure 7B). Moreover, an antibody to the βgc subunit of IGF-1r
co-immunoprecipitated Fz7 only when the GCPs were preincu-
bated with Wnt3a (Figure 7C). In addition, we obtained similar
results by immunoprecipitating proteins from cultures of hip-
pocampal neurons deprived of growth factors for 4 h and kept
in control conditions (no co-immunoprecipitation was observed)
or stimulated for 5min with Wnt3a (Figure 7D). It follows that
binding of Wnt3a to Fz7 promoted the formation of an IGF-1r
(active)-Wnt3a-Fz7 complex at the growth cone of hippocam-
pal pyramidal neurons in culture. To get more information
about the characteristics of this complex we performed SPR
experiments passing the extracellular moiety of Fz7 (aa 45–169)
preincubated (or not) 1:1 with Wnt3a on immobilized IGF-
1r (extracellular moiety). No specific interaction between the
two receptors was detected in this experiment (not shown).
Finally, we performed experiments in order to obtain direct evi-
dence about the participation of the Fz7 receptor in Wnt3a
induced neuronal polarization. For that purpose, we transfected
hippocampal pyramidal neurons with the myc-tagged dominant
negative Fz7 CRD which uncouples the binding of Wnts to Fz7
from the receptor activation (Wei et al., 2011). The results of
these experiments are shown in Figure 8, a quantification of
the transfected neurons indicated that less than 5% of the cells
transfected with Fz7 CRD reached stage 3 of differentiation,
exhibiting a Tau-1 positive axon, compared to over 60% of the
control cells transfected with the plasmid expressing only myc
(Figure 8B).
DISCUSSION
Secreted Wnts interact with their membrane receptors and
activate three different intracellular cascades: (i) The canon-
ical or Wnt/β-catenin pathway, which involves cytosolic sta-
bilization of β-catenin, its translocation to the nucleus, and
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FIGURE 8 | (A) Wnt3a polarizing effect depends on the activation of Fz7.
Double immunofluorescence micrographs of hippocampal neurons incubated
for 24 h in the presence of 1.35 nM Wnt3a showing the distribution of the
axonal marker Tau-1 and the neuronal marker β-III-tubulin. myc is a marker of
transfection with the negative dominant form of Fz7-CRD. Scale bar: 20mm.
(B) Percentage (±sem) of neurons at different stages of differentiation grown
for 20 h in medium containing 1.35 nM Wnt3a and transfected with
pcDNA3.1-myc or Fz7-CRD (n = 3 independent experiments). At least 20
transfected cells were scored for each condition. ∗p < 0.01 compared with
pcDNA3.1-myc.
FIGURE 9 | Wnt3a binds to Fz7 and cross-activate the IGF-1-PI3k-Akt
pathway inducing initial axonal outgrowth and neuronal polarization.
Challenging with 1.35 nM Wnt3a resulted in a polarized distribution of active
(phosphorylated) IGF-1r and phosphorylated p85, the PI3k regulatory
subunit, to one neurite of cells in stage 2 (see Figure 2F).
the transcriptional activation of specific genes; (ii) The pla-
nar cell polarity pathway, which involves the activation of
small Rho-GTPases and kinases that modulate cell orientation
and organization; and (iii) The Wnt/calcium pathway, which
regulates intracellular levels of calcium and the activation of
Ca+2-sensitive kinases (Ciani and Salinas, 2005). To activate
intracellular pathways, Wnts interact with different families of
receptors, such as seven-span transmembrane receptor molecules
known as Frizzled, the co-receptors from the family of low-
density lipoprotein receptor-related proteins (LRP 5/6), and two
atypical tyrosine-kinase receptors Ror1 or 2 and Ryk (Angers
and Moon, 2009). Wnts signal through the novel Ryk recep-
tor via multiple mechanisms, including nuclear translocation of
their intracellular domains and activation of pathways employing
Src family kinases and members of the canonical Wnt pathway
(Fradkin et al., 2010). It has also been shown that one member
of the Wnt family involved in hippocampal formation, Wnt3a,
induces Akt activation via direct activation of PI3k in fibrob-
lasts (Kim et al., 2007). In addition, Wnt3a has been shown to
activate Akt in PC12 cells (Fukumoto et al., 2001). The recep-
tor system(s) involved in PI3k activation by Wnt3a, however,
have not been identified. We have previously shown that acti-
vation of IGF-1r (and activation of PI3k) is essential for polar-
ization of cultured hippocampal pyramidal neurons (Sosa et al.,
2006). The results shown here demonstrate that Wnt3a can pro-
mote initial axonal outgrowth and neuronal polarization in the
absence of IGF-1 and also suggest that Wnt3a is important for
axon maintenance and further axonal outgrowth after polariza-
tion. These results and previously published data prompted us
to investigate the possible activation of PI3k by Wnt3a in cul-
tured hippocampal neurons to identify the receptor(s) involved
in PI3k activation, and determine Wnt3a consequences on ini-
tial axonal outgrowth and neuronal polarization. Surprisingly, we
found that Wnt3a could trigger a robust and significant acti-
vation of IGF-1r, PI3k, and Akt in GCPs (in the absence of
IGF-1 or high insulin; Figures 2A–C). Activation of IGF-1r and
PI3k was polarized to one neurite of cells in stage 2 of differ-
entiation that had not exhibited a noticeable axon (Figure 2C).
Moreover, challenge with Wnt3a in defined medium that did not
contain any growth factors except insulin (5 nM) was sufficient
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to trigger the establishment of neuronal polarity (Figure 1).
Wnt3a polarizing activity required the presence of activat-
able, membrane inserted IGF-1r (Figures 3, 4). Crosslinking
and immunoprecipitation experiments of GCPs challenged with
Wnt3a suggested interaction of Wnt3a with IGF-1r. However,
by SPR experiments no direct interaction between IGF-1r and
Wnt3a was observed neither when IGF-1r was immobilized nor
when Wnt3a was attached to the chip surface (Figures 6C,D).
Thus, SPR results suggested no direct, specific interaction
between these proteins in an isolated system. Finally, by immuno-
precipitation experiments we observed that stimulation with
Wnt3a triggered the formation of a complex containing IGF-
1r-Wnt3a-Fz7. Moreover, we demonstrated that Fz7 is essential
for the Wnt3a observed effects in hippocampal neurons. It fol-
lows that axogenic effects of Wnt3a are due to a polarized
cross-activation of the IGF-1r/PI3k pathway. Interestingly, there
is a significant temporal overlap between high Wnt3a expres-
sion (Lee et al., 2000) and the initial outgrowth of axons in
the hippocampus “in situ” (Fletcher and Banker, 1989). Since
the expression of IGF-1 gene and its transcript is high in
the developing brain but decreases significantly in the adult
(Rotwein et al., 1988; Leroith et al., 1993), the activation of
the IGF-1r by other growths factor, such as Wnts, could sig-
nificantly expand the time window for the activation of this
receptor. A cross-talk between the insulin receptor (homolo-
gous to the IGF-1r) and Wnt have been recently shown in
non-neuronal cells involving co-receptor low density lipoprotein
receptor-related protein-5 (Palsgaard et al., 2012). Besides its cen-
tral role in the establishment of neuronal polarity, the PI3k-Akt
pathways is involved in the regulation of many different phe-
nomena in the central nervous system, including cell division
(during neuronal proliferation), large scale cellular remodeling
(during differentiation-including dendrite and synapses devel-
opment), and synaptic specific changes during plasticity-(Knafo
and Esteban, 2012). Many neurobehavioral disorders arise as a
consequence of subtle developmental abnormalities and aber-
rant PI3k signaling has been indicated by many studies to be a
contributing factor to the pathophysiology of disorders such as
schizophrenia and autism (Waite and Eickholt, 2010). Moreover,
PI3k signaling strongly enhances the resistance of several neu-
ron types against aggressions such us oxidative damage and
hypoxia. It follows that activation of PI3k by Wnt3a, in neurons,
can have a significant physiological and/or pathophysiological
impact.
As discussed above, numerous receptors and co-receptors
have been identified for the members of the Wnt family
growth factors, and Frizzled-3 (Fz3) has been proposed to
have a role in neurite outgrowth and nervous differentia-
tion of glioblastoma cells (Rampazzo et al., 2013). Also, a
mouse Fz3 knock out exhibited defects in axonal outgrowth
and guidance (Wang et al., 2006). In our experimental sys-
tem, however, we did not find detectable expression of Fz3
using two different antibodies (not shown) at least inside
the times of culture used in this study. In contrast, we
found high levels of Fz7 in neurons dissociated from hip-
pocampi at embryonic day 18 (E18) cultured for 20 h and
GCPs prepared from fetal rat brain (E18). A high level of
expression of Fz7 was also found in rat hippocampi (E18)
(Varela-Nallar et al., 2012).
As mentioned above, we did not find evidences indicating
a direct interaction of the IGF-1r with Fz7 bound to Wnt3a
using SPR. Several reasons can explain this observation, includ-
ing: (i) That the presence of transmembrane and/or intracellular
regions of one or both receptors are necessary for the inter-
action, since we used the extracellular moiety of the receptors
in our SPR experiments; (ii) That the interaction between the
receptors is not direct. There are published results that can
support this possibility. For example, cross activation of the
LRP6 receptor by Wnts depends on the formation of a com-
plex containing Frizzled, LRP6, Disheveled-1, and the axin Gsk3
complex (Zeng et al., 2008). Hence, more investigation will be
needed to obtain a complete picture of the components of the
IGF-1r-Wnt3a-Fz7 complex and the characteristics of the bind-
ing of these different components. Interestingly, it has been
recently published that IGF-1 signaling interacts with canoni-
cal Wnt signaling to promote neuronal proliferation (Hu et al.,
2012).
Taken together, our results indicate that cross activation of
the IGF-1r/PI3k pathway by Wnt3a is sufficient for the establish-
ment of neuronal polarity by regulating initial axonal elongation
(a cartoon showing the proposed activation pathway is shown
in Figure 9). Indeed, the present results suggest that Wnt3a,
together with IGF-1, is one of the growth factors initiating axonal
outgrowth in hippocampal neurons.
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